0000899243-21-022988.txt : 20210610
0000899243-21-022988.hdr.sgml : 20210610
20210610170048
ACCESSION NUMBER: 0000899243-21-022988
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210609
FILED AS OF DATE: 20210610
DATE AS OF CHANGE: 20210610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Booth Andrew
CENTRAL INDEX KEY: 0001834411
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39781
FILM NUMBER: 211008798
MAIL ADDRESS:
STREET 1: C/O ABCELLERA BIOLOGICS INC.
STREET 2: 2215 YUKON STREET
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 0A1
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbCellera Biologics Inc.
CENTRAL INDEX KEY: 0001703057
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2215 YUKON STREET
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 0A1
BUSINESS PHONE: (604) 559-9005
MAIL ADDRESS:
STREET 1: 2215 YUKON STREET
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 0A1
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-09
0
0001703057
AbCellera Biologics Inc.
ABCL
0001834411
Booth Andrew
C/O ABCELLERA BIOLOGICS INC.
2215 YUKON STREET
VANCOUVER
A1
V5Y 0A1
BRITISH COLUMBIA, CANADA
0
1
0
0
Chief Financial Officer
Common Shares
2021-06-09
4
S
0
1200000
25.50
D
0
D
Common Shares
116959
I
By spouse
On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50.
/s/ Tryn Stimart, attorney-in-fact
2021-06-10